Annji Pharmaceutical Co., Ltd. (7754) Stock Statistics & Valuation Metrics
Total Valuation
Annji Pharmaceutical Co., Ltd. has a market cap or net worth of TWD 6.10B. The enterprise value is ―.
- Market Cap
- TWD 6.10B
- Enterprise Value
- ―
Share Statistics
Annji Pharmaceutical Co., Ltd. has 101,130,540 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 101,130,540
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Annji Pharmaceutical Co., Ltd.’s return on equity (ROE) is -1.12 and return on invested capital (ROIC) is -74.83%.
- Return on Equity (ROE)
- -1.12
- Return on Assets (ROA)
- -0.61
- Return on Invested Capital (ROIC)
- -74.83%
- Return on Capital Employed (ROCE)
- -0.76
- Revenue Per Employee
- 94.40K
- Profits Per Employee
- -4.47M
- Employee Count
- 80
- Asset Turnover
- 0.01
- Inventory Turnover
- 2.84
Valuation Ratios
The current PE Ratio of Annji Pharmaceutical Co., Ltd. is -14.24. Annji Pharmaceutical Co., Ltd.’s PEG ratio is 0.64.
- PE Ratio
- -14.24
- PS Ratio
- 6421.88
- PB Ratio
- 14.01
- Price to FCF
- -18.22
- Price to Operating Cash Flow
- -17.53
- PEG Ratio
- 0.64
Income Statement
In the last 12 months, Annji Pharmaceutical Co., Ltd. had revenue of 7.55M and earned -357.87M in profits. Earnings per share was -3.78.
- Revenue
- 7.55M
- Gross Profit
- -43.90M
- Operating Income
- -369.37M
- Pretax Income
- -357.87M
- Net Income
- -357.87M
- EBITDA
- -324.21M
- Earnings Per Share (EPS)
- -3.78
Cash Flow
In the last 12 months, operating cash flow was -334.88M and capital expenditures -3.07M, giving a free cash flow of -337.95M billion.
- Operating Cash Flow
- -334.88M
- Free Cash Flow
- -337.95M
- Free Cash Flow per Share
- -3.46
Dividends & Yields
Annji Pharmaceutical Co., Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -5.48%
- Earnings Yield
- -6.90%
Stock Price Statistics
- Beta
- 0.69
- 52-Week Price Change
- 31.41%
- 50-Day Moving Average
- ―
- 200-Day Moving Average
- ―
- Relative Strength Index (RSI)
- 32.63
- Average Volume (3m)
- 551.40K
Financial Position
Annji Pharmaceutical Co., Ltd. as a current ratio of 3.60, with Debt / Equity ratio of 15.43%
- Current Ratio
- 3.60
- Quick Ratio
- 3.42
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 0.92
- Interest Coverage Ratio
- -230.71
Taxes
In the past 12 months, Annji Pharmaceutical Co., Ltd. has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Annji Pharmaceutical Co., Ltd. EV to EBITDA ratio is -16.31, with an EV/FCF ratio of -17.04.
- EV to Sales
- 6005.08
- EV to EBITDA
- -16.31
- EV to Free Cash Flow
- -17.04
- EV to Operating Cash Flow
- -17.20
Balance Sheet
Annji Pharmaceutical Co., Ltd. has TWD 460.26M in cash and marketable securities with TWD 46.30M in debt, giving a net cash position of TWD 413.96M billion.
- Cash & Marketable Securities
- TWD 460.26M
- Total Debt
- TWD 46.30M
- Net Cash
- TWD 413.96M
- Net Cash Per Share
- TWD 4.09
- Tangible Book Value Per Share
- TWD 3.78
Margins
Gross margin is -4637.64%, with operating margin of -41510.74%, and net profit margin of -42332.12%.
- Gross Margin
- -4637.64%
- Operating Margin
- -41510.74%
- Pretax Margin
- -42332.12%
- Net Profit Margin
- -42332.12%
- EBITDA Margin
- -36812.72%
- EBIT Margin
- -41510.74%
Analyst Forecast
The average price target for Annji Pharmaceutical Co., Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- -95.98%
- EPS Growth Forecast
- -25.70%
